All News

The company aims to simplify its customers’ work and thus help them to achieve medical progress and make innovative medicines available faster.

Gene therapies have the potential to revolutionize treatment options for patients suffering from cancer, cystic fibrosis, heart disease, diabetes, Parkinson's, AIDS and Alzheimer's by replacing, inactivating or introducing genes into cells &mda...

The inspection was triggered by data generated by MedPharm as part of a client’s ANDA for a generic topical product.

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

EuTech has recently added two strong professionals in its Management Team. Shekhar Yerramilli has joined as COO and Rick Yglesias has joined as Head of Business Development.

Stevanato and Pfeiffer Vacuum will provide biopharma companies with advanced container closure integrity analysis and testing protocols.

Merck KGaA’s US life science arm, MilliporeSigma, has signed a global licence agreement with biologics technology firm ReForm Biologics to commercialize the latter’s proprietary excipients used in biotherapeutic formulations.

PCI Pharma Services has bought Toronto-based packaging and labelling specialist Bellwyck Pharma Services, adding four GMP-compliant facilities in the US, Germany and Canada to its global network, the CDMO announced Tuesday.

Biopharmaceutical outsourcing has increased markedly in recent years with a greater volume of work previously kept in-house being handed over to third party contractors

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Lonza will invest CHF 12 million (USD 12.3 million) in a catalytic convertor at its Visp manufacturing site to reduce annual emissions of carbon dioxide by 600,000 tons or 98%, the Switzerland-based contract development and manufacturing organisation (...

Rising pharmaceutical cost pressures and volume growth deceleration are forcing pharmaceutical companies to attempt to extract further value from existing medicines rather than solely pursuing new molecules, according to Aurelio Arias, Engagement Manag...

Zenith Technologies CEO, Joe Haugh, takes us through how the business has evolved this year, to better meet the needs of its customers, as well as the trends they see shaping the industry through 2020 and beyond.

CEO says the acquisition of Consort Medical will help to create a leading advanced delivery systems company.

The facility will triple the company’s cGMP clinical trial manufacturing capacity.

TwinMax enabes delivery of doses up to 100 mg formulated as drug alone or engineered particles.

The additional capacity will provide customers with shorter lead times and reduced transportation costs.

Bundling of competencies optimizes workflow of customer projects.

Delpharm and the Famar Group are pleased to announce the acquisition by Delpharm of 5 manufacturing sites belonging to Famar, in France, Canada and the Netherlands. The transaction signed today covers the French sites located in Orléans (Loiret), ...

With CPHI North America fast approaching, we asked several industry experts what they see as the main trends emerging across the US pharma supply chain this year.

Evolving patient needs, growing demand for traceability and increasing cost pressures have awakened innovation in the pharmaceutical packaging sector.

Trijardy XR is a once-daily therapy combining three well-established treatments in one pill.

Sai Life Sciences has initiated the recruitment of 300+ scientists for its upcoming integrated Research & Technology (R&T) centre in Hyderabad, India. This will result in doubling the full-time equivalents (FTEs) in the areas of discovery chemist...

A new drug candidate has been created by artificial intelligence (AI) for the very first time, with the exploratory research route to phase I clinical trials taking less than 12 months, considerably shorter than the typical four and a half years using ...

Amid heightened global concern over the recent coronavirus outbreak, Chinese CDMO WuXi Biologics has sought to reassure customers and patients that its drug supply lines have been unaffected.

ALPLApharma, a new brand of the global packaging specialist ALPLA Group, will introduce itself for the first time to industry professionals at the CPHI Worldwide exhibition.

Agreement will facilitate clinical trial translations in China.

The US Food and Drug Administration has issued India’s Dr Reddy’s Laboratories with five observations after a recent inspection at its active pharmaceutical ingredient (API) manufacturing plant at Srikakulam.

Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.

German company Merck KGaA is investing Euro 250 million in a Swiss biologics facility that bridges manufacturing and research.

As manufacturing industries continue to promote the diverse roles available in science, technology, engineering and mathematics (STEM) disciplines, we turn the spotlight on careers in chemical manufacturing…

Canadian investment firm Nabis Holdings said Tuesday it has agreed to form a joint venture with Israeli pharmaceutical company Panaxia to launch a range of cannabis-based pharmaceutical products in the US state of Arizona in the second half of 2020.

Cognate BioServices, a contract development and manufacturing organization specialising in cell and gene therapy, has completed its purchase of Cobra Biologics, a CDMO specialized in providing development and manufacturing services for plasmid DNA and ...

Biotech firm CNS Pharmaceuticals said Tuesday it has completed pilot manufacturing of a key active pharmaceutical ingredient for its brain tumor drug Berubicin, taking it closer to clinical trials.

If proven safe and effective, mAb CIS43LS might be used prophylactically by tourists, medical workers or military personnel who travel to areas where malaria is common.

Indian CDMO Piramal Pharma Solutions said Tuesday it will invest C$25 million to expand the capacity of its Aurora facility in Canada by 10,500 square feet to house a new wing for manufacturing active pharmaceutical ingredients (APIs).

€250 million to be invested during the 2019-2022 period in new facility bridging research and manufacturing.

The programme will include the launch of next-generation respiratory inhalers, which will use near-zero Global Warming Potential propellants.

UK pharmaceutical firm AstraZeneca has committed to launching its next-generation asthma and chronic pulmonary disease inhaler with near-zero carbon propellants by 2025.

A manifesto making recommendations on how to improve the uptake of vaccines and raise awareness of immunization among European has been presented to the European Commission.

The $470 million investment will support a state-of-the-art facility that produces injectable products and delivery devices.

The International Organization for Standardization (ISO) has published a new standard, named ISO 19577:2019 Critical substances potentially present in footwear and footwear components -- Determination of Nitrosamines.

No need to draw blood; researchers develop smart technology to diagnose diabetes and treat diabetic retinopathy.

The company targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system.

Quality laboratory data is vital to your pharmaceutical development program.

Sai Life Sciences will be in Tokyo for CPHI Japan 2020 during March 16-18, 2020. Please visit booth # 1C - 50 and explore opportunities for collaboration. To schedule an appointment, email contact@sailife.com.

Since 2018, oral dosage CDMO Skyepharma radically updated and expanded its packaging capabilities, opening new packaging lines equipped for serialization and aggregation.

In this exclusive interview, CURE Pharmaceutical COO Jessica Rousset explains her company’s dual pharmaceutical/nutraceutical approach and why the cannabinoid space is ripe for drug delivery innovation

The potential acquisition will see UK CDMO NextPharma develop and broaden its technology offering into lipid-based finished dosage forms

First drug product facility in Europe to complement WuXi Biologics’ existing commercial manufacturing capacities.

Business to focus on intelligent and sustainable technologies.

BMN 307 represents a potential third PKU treatment option from BioMarin and its second gene therapy clinical program.

GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma

The French National Agency for Medicines and Health Product Safety (ANSM) has agreed that Innate Pharma’s Tellomak (lacutamab) Phase II trial can resume recruitment of new patients with relapsed/refractory Sézary syndrome and mycosis fungoides (MF) in ...

PF-05251749 complements the company’s pipeline of potential disease-modifying therapies for Alzheimer’s and Parkinson’s diseases.

Multiple options provide increased flexibility for sponsors.

Biopharma’s desire for fast, cheap production and cell and gene therapy firms’ need for consistency is shaping tech development in the sector.

The product being developed will use proprietary drug formulation technology platform Arestat to deliver new reformulations of existing, complex products.

India’s Lupin Pharmaceuticals warned Monday it could face regulatory sanctions from the US Food and Drug Administration over its Tarapur active pharmaceutical ingredient (API) manufacturing facility.

Dr. Mark Bittinger has joined Sai Life Sciences as Vice President and Global Head of Biology. Mark will be based out of companys' new Discovery Biology facility in Cambridge, Massachusetts, USA, which provides exploratory biology capabilities to the...

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for t...

CPHI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPHI, including CPHI North America—the only event to bring the entire North American pharmac...

Platform gives researchers access to previously undiscovered data to guide evaluation and validation of new drug targets, pathogen identification, disease diagnosis, and the advancement of regenerative medicine.

The US arm of generic and specialty pharma company Mylan Pharmaceuticals has recalled three lots of its heartburn drug Nizatidine in capsule form amid fears of possible nitrosamine contamination.

Includes:
* Spray pattern
* Plume geometry
* Droplet size distribution

Other tests:
* Priming and Repriming
* Dosage
* Dose uniformity

End-to-end robotic platform provides biotechnology companies, pharmaceutical corporations and academic centres with cost-effective and reproducible drug discovery data.

VAV Life Sciences has inaugurated its cGMP compliant phospholipid manufacturing plant in Mirjole, Ratnagiri, Maharashtra.

Expands company's capacity and capability for this novel modality, providing a one-stop shop from preclinical to commercial.

Drug industry expectations of packaging are evolving with developers now seeking techs that help patients get more from their medicines.

Mutations in the RIPK1 gene responsible for CRIA syndrome.

Capacity to serve global late-stage development and commercial manufacturing of monoclonal antibody drug substance to support new product launches.

Collaboration discovers potent and selective inhibitors of enzymes associated with the development of some cancers and neurodegenerative diseases.

Acquisition adds talent and proprietary therapeutic platform to accelerate next-generation cancer immunotherapy.

Botox and Botox Cosmetic (onabotulinumtoxinA) hold 14 therapeutic and aesthetic indications combined, more than any other neurotoxin in the world.

Next-generation pharmaceutical supply-chain security for tracking product from plant to patient.

Customers and partners look set to benefit from reduced development times and costs of medical drugs.

We asked ten industry experts for their thoughts on some of the emerging trends for the pharmaceutical supply chain as the industry enters 2020...

The investment enhances the supply chain robustness of products manufactured for the makers of solid oral dosage products.

Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports.

CMO's customer base has grown by more than 25% in 2019 alone, and investment and demand for services is estimated to increase output by another 25-30% in 2020.

The past 12 months have been busy as many companies fought to comply with serialization regulations.

Represents the first biopackaging of its kind made of renewable raw materials.

The Chemical & Engineering News, arguably the world's most comprehensive and authoritative news source about chemistry and related fields, featured Sai Life Sciences in its report covering CPHI Worldwide 2019.

Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced Sai Nxt, an organization-wide initiative aimed at transforming the company into a new generation CDMO.

NEI-led study to test safety of treatment for a form of age-related macular degeneration that currently lacks treatment.

New CTSuccess service helps to reduce the risk of delays and budget overspend.

The fast-dispersing Zydis formulation could increase compliance with Medication-Assisted Treatment and thus better clinical outcomes.

Smart tags on pills set to improve supply chain security and patient adherence.

The US pharmaceutical industry continues to lead its global peers in terms of innovation and competitiveness, while still ranking high in overall growth potential despite its mature status, according to the results of a survey of 350 global pharmaceuti...

Installation of a SprayVIEW system will help the CDMO to support customers in both innovative and generic inhalation and nasal product development.

Phosphorus trichloride (PCl3) and phosphorus oxychloride (POCl3) are raw materials used on a large scale during the synthesis of pharmaceuticals. They are used for both the production of Active Pharmaceutical Ingredients (API) and intermediates of thos...

Lead asset THOR-707 being explored across multiple solid tumor types alone and in combination with immune checkpoint inhibitors and other future IO combinations.

Expansion increases capacity for the company's topical and transdermal services, as well as dedicated innovation, microbiology and histology laboratories.

Borealis and Borouge announce the launch of a new service solution.

Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.

New innovation has considerable potential to be used as a new environmentally friendly matrix for the microencapsulation and controlled release of a wide range of actives.

Lilly Gateway Labs will provide biotech companies direct access to Lilly scientists and expertise.

Unprecedented levels of investment cited as a major force driving the expansion.

The financial backing will help the company to develop a new generation of microbial air monitors that enables continuous monitoring as demanded by the Annex 1 revision.

ClearMixx performs liquid/liquid and powder/liquid mixing, with a dispersion plate able to efficiently mix the most challenging buffer, media and biopharmaceutical ingredients.

Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.

The largest area of growth has been within biotechnology companies, where job openings increased by 35%.

The company's diabetes nutrition drink, Celevida, is formulated to help manage blood glucose levels.

The rise in exports growth potential is believed to be in response to concerted reforms by the CDSCO and industry quality improvements in the last few years.

Robinson Brothers is pleased to announce that Jamie Wilkes, Pilot Plant Technician, has been awarded Young Apprentice of the Year as part of the prestigious Black Country Chamber of Commerce Awards 2019.

Company's multimillion euro investment will enable it to meet growing market demands from clients providing cancer treatments.

The new center will provide expertise in critical analytical processes and specialized workflows.

The device's blister is designed to provide flexibility to pharmaceutical partners delivering a wide range of inhaled drugs for both acute and chronic respiratory treatments.

The CDMO offers to acquire Consort Medical to become a Top Five global CDMO player.

Marks the latest step in the company’s ongoing efforts to engage with other organisations working to tackle antimicrobial resistance.

New models can help researchers investigate disease development and find new treatment approaches.

The device supports the new EU GMP Annex 1 requirements.

We are the major player with excellent expertise in manufacturing of ORNIDAZOLE, IRON SUCROSE, MEFENAMIC ACID, FLUCONAZOLE, GLIMEPIRIDE, TIZANIDINE, DFTA, Α-KETOANALOGUES TO ISOLEUCINE/LEUCINE/PHENYLALANINE/VALINE/METHIONINE, TOLFENAMIC ACID, BENFOTIAM...

China-US trade challenges has led to de-risking by pharma companies.

Companies and individuals from across the whole pharma supply chain recognised for their excellence and commitment.

Kappa Bioscience, maker of K2VITAL® vitamin K2-7, will co-exhibit at CPHI in Delhi Nov 26-28 alongside distributor S. A. Pharmachem Pvt. Ltd. of Mumbai. These companies announced a first-of-its-kind drug import license for vitamin K2 in India at CPHI18...

But personalized medicines will require new logistics and manufacturing systems.

Partnership will combine capabilities and expertise in Europe and India to build a new facility dedicated to injectable formulations to supply demand from Europe and overseas territories.

Good blisters only

CAM are glad to announce that a new seat for Campak India is now open. Campak India is the company responsible for the marketing and technical support for all CAM m